April 14 | 2025
EARLY NOTICE OF ANNUAL GENERAL MEETING OF 2CUREX AB (publ)
Read more
February 27 | 2025
2cureX publishes interim report for the second half year of 2024
Read more
January 20 | 2025
2CUREX APPOINTS MANGOLD FONDKOMMISSION AB TO ACT AS A LIQUIDITY PROVIDER FOR THE COMPANY’S SHARE
Read more
January 10 | 2025
Correction: 2CUREX APPOINTS MANGOLD FONDKOMMISSION AB TO ACT AS A LIQUIDITY PROVIDER FOR THE COMPANY’S SHARE
Read more
January 10 | 2025
2CUREX APPOINTS MANGOLD CORPORATE FINANCE TO ACT AS A LIQUIDITY PROVIDER FOR THE COMPANY’S SHARE
Read more
December 18 | 2024
KOMMUNIKÉ FRÅN EXTRA BOLAGSSTÄMMA I 2CUREX AB (PUBL)
Read more
December 18 | 2024
BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN 2CUREX AB (PUBL)
Read more
December 16 | 2024
2cureX AB Announces the Appointment of Dan Honeywell as CEO, Ushering in a New Era of commercial expansion of breakthrough precision oncology products
Read more
November 29 | 2024
KALLELSE TILL EXTRA BOLAGSSTÄMMA I 2CUREX AB
Read more
November 29 | 2024
NOTICE OF EXTRA GENERAL MEETING IN 2CUREX AB
Read more
September 24 | 2024
BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN 2CUREX AB (PUBL)
Read more
September 24 | 2024
KOMMUNIKÉ FRÅN EXTRA BOLAGSSTÄMMA I 2CUREX AB (PUBL)
Read more
September 9 | 2024
Invitation to 2cureX Webcast with Q&A on 24 September 2024
Read more
September 4 | 2024
NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF 2CUREX AB (PUBKL)
Read more
August 22 | 2024
2cureX publishes interim report for the first half year of 2024
Read more
July 12 | 2024
KOMMUNIKÉ FRÅN EXTRA BOLAGSSTÄMMA I 2CUREX AB (PUBL)
Read more
July 1 | 2024
KOMMUNIKÉ FRÅN ÅRSSTÄMMAN I 2CUREX AB (PUBL)
Read more
June 28 | 2024
RELEASE OF THE 2CUREX AB (PUBL) ANNUAL REPORT
Read more